Panayiotis Alexandrou Procopiou

This inventor holds 28 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Glaxo Group Limited, Glaxosmithkline Intellectual Property Development Limited, Smithkline Beecham Corporation. Active years: 1989-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Panayiotis Alexandrou Procopiou. Retrieved from https://idiyas.com/inventor/panayiotis-alexandrou-procopiou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 4)

% Patents Active = 32.1

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 113(Granted Patents)

Location History:

Harrow, GB (1989 - 1992)
Stevenage, GB (2000 - 2019)

Company Filing History:

Glaxosmithkline Intellectual Property Development Limited

patents

2 out of 2,198

Smithkline Beecham Corporation

Years Active: 1989-2019

Loading Chart...

Areas of Expertise:

Integrin Antagonists

Naphthyridine Derivatives

Phenethanolamine Derivatives

Respiratory Diseases

H1 Receptor Antagonists

CCR4 Receptor Antagonists

Inflammatory Disorders

Medicinal Compounds

Agonists

Heterocyclic Compounds

Pharmaceutical Compositions

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10513517 - Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases (2019-12-24),

2. 10487080 - Naphthyridines as integrin antagonists (2019-11-26),

3. 10144733 - Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases (2018-12-04),

4. 10004724 - Compounds alpha v beta 6 integrin antagonists (2018-06-26),

5. RE44874 - Phenethanolamine derivatives for treatment of respiratory diseases (2014-04-28),

6. 8507543 - Compounds (2013-08-13),

7. 8357716 - Pyrazole derivatives used as CCR4 receptor antagonists (2013-01-22),

8. 8198483 - Phenethanolamine derivatives for treatment of respiratory diseases (2012-06-12),

9. 7989629 - 3-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders (2011-08-02),

10. 7982067 - Phenethanolamine derivatives for treatment of respiratory diseases (2011-07-19),

11. 7884114 - Compounds (2011-02-08),

12. 7776895 - Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases (2010-08-17),

13. 7538127 - Medicinal compounds (2009-05-26),

14. 7442839 - Phenethanolamine derivative for the treatment of respiratory diseases (2008-10-28),

15. 7442837 - Phenethanolamine derivatives for treatment of respiratory diseases (2008-10-28),

Title: Panayiotis Alexandrou Procopiou - Innovator from Stevenage

Introduction: Panayiotis Alexandrou Procopiou is a renowned inventor hailing from Stevenage, Great Britain. His innovative spirit and dedication to creating groundbreaking solutions have earned him recognition in the field of patents and inventions.

Latest Patents: Panayiotis Alexandrou Procopiou holds several patents in various industries, showcasing his versatility and creativity in developing new technologies to address modern challenges.

Career Highlights: Throughout his career, Panayiotis Alexandrou Procopiou has demonstrated a keen ability to transform ideas into tangible inventions. His contributions have significantly impacted sectors such as technology, healthcare, and sustainability.

Collaborations: Panayiotis Alexandrou Procopiou has collaborated with leading companies, research institutions, and universities to further his innovative projects. These partnerships have allowed him to leverage diverse expertise and resources to bring his inventions to life.

Conclusion: Panayiotis Alexandrou Procopiou's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His legacy as a visionary creator remains a testament to the power of ingenuity and perseverance in driving positive change.

Profile summary based on public USPTO records.